Sugar diabetes
According to the World Health Organization (WHO) the total number of people suffering from sugar diabetes globally had significantly increased to a total of 170 million by the mid parts of 2008 with a prediction of an increase in over two fold by the quarter of this century. It is estimated that almost 20 million of the population of the United States are living with chronic and terminal diabetes.
Diabetes is a disease that occurs as a result of failure of the pancreas to generate the insulin hormone needed to breakdown complex sugars into simple forms for assimilation. The effect of the disease on the victim largely depends on the level of secretion of the insulin hormone. The shortage or visible absence of the hormone in the human system results in an abnormally high pile of glucose in the bloodstream instead of the cells that need it. Thanks to research, the artificial insulin hormone was developed as the most standard form of managing the disease until recent innovations opened new doors. During the 2005 financial year the total global industry for the production and sale of diabetes management drugs were pegged at a total of $15 billion. Artificial insulin constituted the largest product sold with a contribution of a little above $6 billion.
It is against this background that AD&K Pharmaceuticals after critically studying the market structure for diabetes management related drugs have come out with the most comprehensive and effective method of managing the disease. The introduction of “TIMSUM” unto the market provides the most credible alternative to the daily insulin injection dose that patients have to use to manage diabetes. Unlike the insulin hormone injection TIMSUM makes use of laser technology to penetrate the blood stream to neutralize the effects of the complex sugars piled up in the bloodstream. In order words the diabetes patient does not have to bother about natural insulin secretion or not. TIMSUM has the capacity to restore the sugar level to optimum standards without altering the PH level of the blood.
The advent of TIMSUM unto the market is intended to achieve two major goals namely: providing absolute relief to the numerous diabetes patients the world over and also igniting a revolution in the pharmaceutical industry such that in the next couple of years the corporate objectives of AD&K Pharmaceuticals Inc would have being achieved because the commanding heights of the industry will be reasonably under its control.
Processing your request, Please wait....
